Morphoceuticals Raises $8 million to Advance Electroceutical Approach to Regenerative Medicine
February 15, 2023 - Boston, MA – Morphoceuticals Inc., a biotechnology company, announced it closed an $8 million Seed-2 funding round led by Prime Movers Lab and initial investor Juvenescence. Mor...
Juvenescence joins Banco Português de Fomento and 200M Fund in co-investment in Chrysea Laboratories
Juvenescence joins the 200M Fund portfolio in the investment in Chrysea Labs (“Chrysea”), a synthetic biology company developing high-value and difficult to source natural products, using proprieta...
New Study: Active Ingredient in Metabolic Switch Induces Ketosis
A recent study published in the Journal of American Nutrition Association shows that bis hexanoyl (R)-1,3-butanediol (BH-BD), the active ingredient in Metabolic Switch®, induces ketosis.
Juvenescence Puts the Focus on National Keto Day with Metabolic Switch
January 5 is National Keto Day. Started two years ago by The Vitamin Shoppe, the day serves to bring awareness to the ketogenic diet and its health benefits.
Juvenescence Debuts New Product to Aid in Supporting a Healthy Metabolism
Juvenescence Ltd., a longevity biotech and life sciences company announced the launch of Metabolic Switch®, an evidence-based, breakthrough C6 Ketone Di-ester drink that puts the consumer in ketosi...
Juvenescence Appoints Dr. Grazia Piizzi as Chief Scientific Officer
Juvenescence announces that Dr. Grazia Piizzi has joined its Executive Management Team as Chief Scientific Officer.
